78 related articles for article (PubMed ID: 36237241)
21. Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance.
Ding Z; Li Y; Chen A; Song M; Zhang Y
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():32-36. PubMed ID: 27816739
[TBL] [Abstract][Full Text] [Related]
22. Detection of HPV E6/E7 mRNA in the diagnosis of cervical cancer and precancerous lesions after kidney transplantation.
Sun J; Yue Y; Li R; Sun Q; Hu C; Ge X; Guan Q
Am J Transl Res; 2021; 13(6):7312-7317. PubMed ID: 34306499
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of clinical features of cervical precancerous lesions in postmenopausal women].
Liu YY; Guo RX; Li BJ; Wu Y; Bai J; Li LX; Wang CF
Zhonghua Fu Chan Ke Za Zhi; 2021 Feb; 56(2):114-120. PubMed ID: 33631883
[No Abstract] [Full Text] [Related]
24. [Analysis of clinical and pathological characteristics of high- risk HPV-negative carcinoma of the uterine cervix].
Li ZM; Zeng LQ; Peng XH; Mao LZ; Sun XL; Li YH; Luo XP
Zhonghua Fu Chan Ke Za Zhi; 2016 Sep; 51(9):683-687. PubMed ID: 27671050
[No Abstract] [Full Text] [Related]
25. Diagnostic value of high-risk human papillomavirus viral load on cervical lesion assessment and ASCUS triage.
Wang M; Hou B; Wang X; Han L; Shi Y; Zhang Y; Zhang L; Liu L; Jin F; Zhang Y
Cancer Med; 2021 Apr; 10(7):2482-2488. PubMed ID: 33682355
[TBL] [Abstract][Full Text] [Related]
26. Application of TruScreen in detecting ASCUS patients.
Li W; Guo Y; Niu H; Jin S; Wang L
Asian Pac J Trop Med; 2011 Aug; 4(8):669-71. PubMed ID: 21914550
[TBL] [Abstract][Full Text] [Related]
27. Retrospective analysis of cervical cancer and precancerous lesions in patients with atypical squamous cells of undetermined significance in China.
Wang YY; Kong LH; Liu Y; Wang S; Fan QB; Zhu L; Lang JH
Medicine (Baltimore); 2019 Dec; 98(49):e18239. PubMed ID: 31804350
[TBL] [Abstract][Full Text] [Related]
28. The utility of high-risk HPV testing in the management of women 30 to 64 years of age with low-grade squamous intraepithelial lesions on cervical cytology.
Selvaggi SM
J Am Soc Cytopathol; 2015; 4(5):290-293. PubMed ID: 31051767
[TBL] [Abstract][Full Text] [Related]
29. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
[TBL] [Abstract][Full Text] [Related]
30. Racial differences in HPV type 16 prevalence in women with ASCUS of the uterine cervix.
Risley C; Clarke MA; Geisinger KR; Stewart MW; Zhang L; Hoover KW; Hiser LM; Owens K; DeMarco M; Schiffman M; Wentzensen N
Cancer Cytopathol; 2020 Aug; 128(8):528-534. PubMed ID: 32243726
[TBL] [Abstract][Full Text] [Related]
31. Value of TCT combined with HPV and CA125 in early cervical cancer screening in a medical examination population.
Xiao M; Zhang Z; Yu X; Fan Y; Chen X
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(9):160-164. PubMed ID: 36905257
[TBL] [Abstract][Full Text] [Related]
32. Clinical utility of HPV typing and quantification combined with PAX1/ZNF582 methylation detection in accurate cervical cancer screening.
Wen Y; Liang H; Zhang H
Cytojournal; 2023; 20():26. PubMed ID: 37681081
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic Management of Oncogenic HPV Cervical Infections: The Field Experience in Wuxi, China.
Liu Y; Yin Y; Zhang Y; Lin L; Zhao M; Chen Q
Front Med (Lausanne); 2022; 9():825228. PubMed ID: 35402444
[TBL] [Abstract][Full Text] [Related]
34. Factors Associated with Lesion Recurrence Following Cervical Conization.
Zhao J; Liu X; Gao J; Xiao H; Jin Y; Wang Y; Ma W
Altern Ther Health Med; 2023 Sep; 29(6):50-55. PubMed ID: 37442183
[TBL] [Abstract][Full Text] [Related]
35. Follow-up study on ThinPrep cytology test-positive patients in tropical regions.
Chen YC; Liang CN; Wang XF; Wang MF; Huang XN; Hu JD
World J Clin Cases; 2022 Dec; 10(34):12543-12550. PubMed ID: 36579088
[TBL] [Abstract][Full Text] [Related]
36. Optimal Screening and Detection Strategies for Cervical Lesions: A Retrospective Study.
Yang Y; Xu L; Yuan S; Lv J; Chen P; Wang W
J Cancer; 2024; 15(11):3612-3624. PubMed ID: 38817879
[No Abstract] [Full Text] [Related]
37. The Cellient System for Paraffin Histology Can Be Combined with HPV Testing and Morphotyping the Vaginal Microbiome Thanks to BoonFixing.
Boon ME
Obstet Gynecol Int; 2013; 2013():502357. PubMed ID: 23577033
[TBL] [Abstract][Full Text] [Related]
38. Screening of Precancerous Lesions in Women with Human Papillomavirus (HPV) Infection by Molecular Typing and MicroRNA Analysis.
Varesano S; Pulliero A; Martorana E; Pizzino G; Raciti G; Coco S; Vellone VG; Izzotti A
J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983713
[TBL] [Abstract][Full Text] [Related]
39. The Follow-Up Necessity in Human Papilloma Virus-Positive vs. Human Papilloma Virus-Negative Oral Mucosal Lesions: A Retrospective Study.
Rushiti A; Castellani C; Cerrato A; Fedrigo M; Sbricoli L; Bressan E; Angelini A; Bacci C
J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202065
[TBL] [Abstract][Full Text] [Related]
40. Meta-analysis of the effect and safety of recombinant human interferon α-2b combined with Baofukang suppository in the treatment of HPV infection.
He C; Song C; Li M; Ma W; Sun S
Am J Transl Res; 2022; 14(11):7632-7642. PubMed ID: 36505291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
